OrgaranOrgaran (Danaparoid Sodium). This site is for UK health care professionals only.

Clinical presentation



  • The importance of HIT is related to its paradoxical association with a very high risk of thromboembolic events2. Therefore heparin, as an anticoagulant can, when HIT occurs, induce a highly thromboembolic state.


  • These events include but are not confined to: - peripheral arterial occlusion - acute myocardial infarction - stroke4.


  • The associated mortality with these events is high. In addition, venous thromboembolic disease (VTE) is very strongly associated with HIT5.


  • The ratio of venous to arterial thrombotic events is approximately 4:1with pulmonary embolism (PE) occurring in approximately 25% of all patients diagnosed with HIT5.


  • Other thrombotic manifestations of HIT are: - adrenal hemorrhagic necrosis, probably as a consequence of adrenal vein thrombosis6. - venous limb gangrene7. - Approximately 10-20% of patients develop limb-threatening ischaemia.


  • Although co-morbid events related to underlying disorder complicate estimates of HIT-related mortality, it is thought that the overall HIT-associated mortality is approximately 20-30%5


  • What triggers HIT?


  • The disorder is triggered by heparin regardless of dose or route of administration, including flushes administered to maintain patency of intravascular catheters.

Contact information

Organon Laboratories Ltd
Cambridge Science Park
Milton Road
Cambridge
CB4 0FL
Telephone 01223 432700
Fax 01223 424368
(www.organon.co.uk)


© 2008 Organon Laboratories. All rights reserved. Date of prep. November 2008. Item code: 09847G